Sever Pharma Solutions Recognized in Citeline’s 2024 Medicon Valley Report
Sever Pharma Solutions is proud to be prominently featured in the 2024 Citeline Annual Report on Medicon Valley, an essential resource for monitoring innovations and achievements in one of Europe’s most vibrant life sciences clusters. This report, created in collaboration with the Medicon Valley Alliance, showcases key companies driving growth in pharmaceutical manufacturing and research, with Sever Pharma Solutions acknowledged for its groundbreaking advancements in controlled-release systems and polymer-based drug delivery solutions.
Headquartered in Malmö, Sever Pharma Solutions shines as a leader in developing, manufacturing, and optimizing highly potent, controlled-release medications. The company has excelled in crafting advanced polymer-based delivery systems that meet critical pharmaceutical therapy needs, mainly through innovative solutions that enhance drug stability, efficacy, and patient outcomes. The company’s acquisition of Foster Delivery Science in the U.S. broadened its global research presence, providing a competitive advantage in developing injectable biodegradable ocular implants—an area of considerable unmet demand. This strategic move has enabled Sever Pharma Solutions to explore new therapeutic domains and solidify its commitment to enhancing patient care with complex, precision-engineered pharmaceutical products.
Medicon Valley’s vibrant ecosystem offers Sever Pharma Solutions unique advantages, including access to top universities and research institutions in Sweden and Denmark, fostering collaboration, and a highly skilled workforce. Supported by both local and international investments, this ecosystem propels Sever Pharma Solutions’ vision to challenge boundaries within the pharmaceutical industry. The company’s role in this community strengthens Medicon Valley’s stature as a world-class life sciences hub, where Sever Pharma Solutions continues to expand its capabilities and advance pharmaceutical innovations.
As a key player in Medicon Valley, Sever Pharma Solutions is eager to enhance its contributions to this innovation cluster, developing solutions that shape the future of medicine and solidifying its reputation as a trusted partner in advanced pharmaceutical manufacturing.
